Sotera Health (NASDAQ:SHC) Director Gtcr Investment Xi Llc Sells 12,000,000 Shares of Stock

Sotera Health Company (NASDAQ:SHCGet Free Report) Director Gtcr Investment Xi Llc sold 12,000,000 shares of Sotera Health stock in a transaction on Monday, November 10th. The stock was sold at an average price of $15.65, for a total transaction of $187,800,000.00. Following the transaction, the director directly owned 29,215,301 shares of the company’s stock, valued at $457,219,460.65. The trade was a 29.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Gtcr Investment Xi Llc also recently made the following trade(s):

  • On Friday, September 5th, Gtcr Investment Xi Llc sold 8,000,000 shares of Sotera Health stock. The shares were sold at an average price of $15.11, for a total transaction of $120,880,000.00.

Sotera Health Price Performance

Sotera Health stock opened at $16.25 on Thursday. Sotera Health Company has a 12-month low of $9.53 and a 12-month high of $17.78. The company has a current ratio of 2.38, a quick ratio of 2.18 and a debt-to-equity ratio of 4.04. The firm has a 50-day moving average price of $16.10 and a 200-day moving average price of $13.89. The firm has a market capitalization of $4.62 billion, a PE ratio of 85.53 and a beta of 1.82.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on SHC shares. Piper Sandler boosted their target price on Sotera Health from $15.00 to $17.00 and gave the company a “neutral” rating in a research report on Wednesday, November 5th. Barclays lifted their target price on Sotera Health from $19.00 to $20.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. Wall Street Zen raised shares of Sotera Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 16th. JPMorgan Chase & Co. boosted their price objective on shares of Sotera Health from $14.00 to $16.00 and gave the company a “neutral” rating in a research report on Wednesday, November 5th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Sotera Health in a research note on Friday, October 31st. Three investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $17.40.

View Our Latest Stock Analysis on SHC

Hedge Funds Weigh In On Sotera Health

Several institutional investors have recently bought and sold shares of SHC. Teacher Retirement System of Texas purchased a new stake in Sotera Health during the first quarter worth $266,000. Principal Financial Group Inc. boosted its holdings in shares of Sotera Health by 0.3% in the 1st quarter. Principal Financial Group Inc. now owns 352,388 shares of the company’s stock valued at $4,109,000 after buying an additional 1,037 shares in the last quarter. Victory Capital Management Inc. raised its stake in shares of Sotera Health by 5.7% during the 1st quarter. Victory Capital Management Inc. now owns 57,655 shares of the company’s stock worth $672,000 after acquiring an additional 3,106 shares in the last quarter. XTX Topco Ltd acquired a new stake in Sotera Health in the first quarter valued at approximately $602,000. Finally, Charles Schwab Investment Management Inc. increased its position in shares of Sotera Health by 5.1% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,415,282 shares of the company’s stock worth $16,502,000 after purchasing an additional 68,087 shares in the last quarter. 91.03% of the stock is owned by hedge funds and other institutional investors.

About Sotera Health

(Get Free Report)

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

Featured Stories

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.